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http:WHAT THIS PAPER ADDS
FDG-PET scanning is a new tool for the diagnosis of central vascular graft infections. However, little is known
about which FDG uptake patterns are associated with uncomplicated central vascular graft implantations. This
paper is the ﬁrst to study the typical FDG uptake patterns of uninfected and infected grafts, offering information
which may inﬂuence the further use of FDG-PET scanning in the diagnosis of vascular graft infections.Objective: 18F-ﬂuorodeoxyglucose (FDG) positron emission tomography (PET) scanning has been suggested as a
means to detect vascular graft infections. However, little is known about the typical FDG uptake patterns
associated with synthetic vascular graft implantation. The aim of the present study was to compare uninfected
and infected central vascular grafts in terms of various parameters used to interpret PET images.
Methods: From 2007 through 2013, patients in whom a FDG-PET scan was performed for any indication after
open or endovascular central arterial prosthetic reconstruction were identiﬁed. Graft infection was deﬁned as the
presence of clinical or biochemical signs of graft infection with positive cultures or based on a combination of
clinical, biochemical, and imaging parameters (other than PET scan data). All other grafts were deemed
uninfected. PET images were analyzed using maximum systemic uptake value (SUVmax), tissue to background
ratio (TBR), visual grading scale (VGS), and focality of FDG uptake (focal or homogenous).
Results: Twenty-seven uninfected and 32 infected grafts were identiﬁed. Median SUVmax was 3.3 (interquartile
range [IQR] 2.0e4.2) for the uninfected grafts and 5.7 for the infected grafts (IQR 2.2e7.8). Mean TBR was 2.0
(IQR 1.4e2.5) and 3.2 (IQR 1.5e3.5), respectively. On VGS, 44% of the uninfected and 72% of the infected grafts
were judged as a high probability for infection. Homogenous FDG uptake was noted in 74% of the uninfected and
31% of the infected grafts. Uptake patterns of uninfected and infected grafts showed a large overlap for all
parameters.
Conclusion: The patterns of FDG uptake for uninfected vascular grafts largely overlap with those of infected
vascular grafts. This questions the value of these individual FDG-PET-CT parameters in identifying infected grafts.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Central vascular prosthetic graft (CVG) infections are asso-
ciated with morbidity and mortality rates of up to 50%.1e3 As
the diagnosis often leads to substantial surgical procedures,
obtaining proof of the infection is essential. Symptoms are
often non-speciﬁc, thus the diagnosis relies heavily on
medical imaging.4 While a false negative test result may leadresponding author. Dr. J. Rontgenlaan 60, 3723 LC Bilthoven, The
lands.
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//dx.doi.org/10.1016/j.ejvs.2015.06.007to under-treatment, a false positive test result may lead to
unnecessary surgery. Considering the vulnerable patient
population, any mis-classiﬁcation of the test outcomes will
have a negative impact on the prognosis. Therefore, a diag-
nostic tool is needed with the ability to discriminate well
between the presence and the absence of a CVG infection.
Recently, positron emission tomography scanning (PET
scan) using 18F-ﬂuorodeoxyglucose (FDG) has been sug-
gested to be valuable in the diagnostic process of CVG in-
fections.5e9 18F-FDG PET scanning is based on the uptake of
radioactive labeled 18F-FDG (a glucose analog) in metabol-
ically active cells. Infectious and inﬂammatory processes
show uptake of FDG.10
Synthetic vascular grafts have been shown to provoke a
chronic low grade inﬂammation which is a potential uptake
Differential FDG-PET Uptake Patterns 377source for FDG.11 FDG uptake has also been shown to occur
in uninfected aortic vascular grafts. However, little is known
about “normal” FDG uptake patterns, associated with the
implantation of a synthetic vascular graft.6,10,12e14 There-
fore, the aim of this study was to assess the FDG uptake
patterns in uninfected and infected CVG, comparing
maximum standardized uptake value (SUVmax), tissue to
background ratio (TBR), visual grading scale (VGS), and
focality of FDG uptake between uninfected and infected
central vascular grafts.MATERIAL AND METHODS
Patients treated by open or endovascular central vascular
reconstructions in a tertiary referral center were retrospec-
tively included from January 1, 2007 to December 31, 2013.
Patients were identiﬁed through the hospital registration
system using the Dutch ﬁnancial codes for open and endo-
vascular central vascular reconstructions (Appendix I). Cen-
tral vascular grafts were deﬁned as non-peripheral vascular
grafts and contained (1) open and/or endovascular centralFigure 1. Datavascular reconstructions; (2) abdominal grafts; (3) thoracic
grafts; and (4) centrally located extra-anatomic re-
constructions (axillo-femoral reconstructions and femoro-
femoral reconstructions). All surgical reports were
reviewed to identify patients meeting these inclusion
criteria. Strictly infra-inguinal grafts were excluded.
This dataset was merged with the local nuclear medicine
registration system to identify patients in whom a FDG-PET
scan was performed, irrespective of the indication for im-
aging. Only patients in whom a FDG-PET scan was per-
formed after graft implantation, for any indication, were
included in the present study. Incomplete PET scans were
excluded (Fig. 1).
Basic patient characteristics and data on the primary aortic
reconstruction were recorded. Comorbidities were deﬁned
as recommended by the Ad Hoc Committee on Reporting
Standards.15 The medical records were searched for clinical
signs of infection (body temperature above 38.5 Celsius,
ﬂuid surrounding the graft, incisional ﬁstula, exposed grafts,
and deep wound infections) at the time of the PET scan.
Laboratory infection parameters at the time of the PET scancollection.
378 P. Berger et al.were recorded (white blood cell counts, C-reactive protein,
sedimentation rate, positive blood cultures).
Uninfected was deﬁned as absence of clinical and
biochemical signs of graft infection or ultimate rejection of
vascular graft infection by a combination of biochemical,
clinical, and imaging parameters (other than PET scan)
despite initial positive clinical or biochemical signs of a graft
infection. Infection was deﬁned as the presence of clinical
or biochemical signs of a graft infection with positive cul-
tures or based on a combination of clinical, biochemical,
and imaging parameters (other than PET scan data). In case
of multiple grafts, each graft was scored separately. Only
the ﬁrst PET scan after graft implantation was scored
(Fig. 1).FDG-PET imaging
FDG-PET scans were acquired using a FDG-PET scanner
(Siemens Biograph Sensation 16, Germany). Subjects
received an intravenous injection of FDG at 2.0 MBq/kg of
body weight. Patients were hydrated with 1000 mL of water
1 hour prior to image acquisition. Blood glucose levels were
checked in all patients before FDG injection, and no patients
had blood glucose levels greater than 160 mg/dL. Approx-
imately 1 hour after FDG injection, the FDG-PET scan was
performed. An emission PET scan was obtained with
3 minute acquisitions per bed position using a 3 dimen-
sional acquisition mode. After PET scanning a low dose CT
was performed for attenuation correction. In case of mul-
tiple grafts, all grafts were scored separately.Image analysis
All images were analyzed by two independent, experienced
nuclear medical physicists (NMP) on a digital workstation,
blinded for the clinical data. The following features were
used to further analyze and quantify the images: SUVmax,
TBR, VGS, and focality of FDG uptake (focal or homogenous)
TBR was deﬁned as SUVmax divided by SUVmax of the
bloodpool. The intensity of FDG uptake was graded on a 5
point scale (VGS) as follows:grade 0: FDG uptake similar to that in the background
grade 1: low FDG uptake, comparable to that of
inactive muscles and fat
grade 2: moderate FDG uptake, clearly visible and
higher than the uptake by inactive muscles and fat
grade 3: strong FDG uptake, but distinctly less than
the physiological urinary uptake by the bladder
grade 4: strong FDG uptake, comparable with the
physiological urinary uptake by the bladder.5Based on the visual grading scale, the probability of
prosthetic infection on FDG-PET scanning was classiﬁed as
low or high (visual grades 0, 1, or 2 were deﬁned as low,
visual grades 3 or 4 were deﬁned as high). Focal FDG uptake
was deﬁned as well circumscribed areas of increased uptake
in connection with the graft. For the ﬁnal conclusion, a 5
point Likert scale was used: clearly not infected, probablynot infected, doubtful, probably infected, and clearly
infected.16,17 Examinations were reviewed in three orthog-
onal views. Fused PET/CT images were used to correlate the
PET signal with morphological ﬁndings. In all examinations,
1 cm or larger circular regions of interest (ROIs) were
drawn. Differences of opinion between the observers with
regard to the VGS, focality, and ﬁnal conclusion were
resolved by discussion and ended in a consensus.Statistical analysis
Baseline characteristics were presented as median and
interquartile range (IQR) or percentages. Differences be-
tween the uninfected and infected graft groups were tested
using the independent t test and chi-square test. For SUV-
max and TBR, a receiver operating characteristic (ROC)
curve was plotted and the AUC (area under the ROC curve)
with 95% CI was calculated. Using the cutoff point with the
highest sensitivity and speciﬁcity from the AUC curves, a
threshold value for SUVmax and TBR was determined. Data
were calculated for both observers. Means and standard
deviations between both observers were very much equal.
Correlations were 0.83 and 0.84, respectively. Because of
these high correlations and the fair amount of agreement
between observers, only data from observer 1 are pre-
sented. Where opinions on VGS, focality, and ﬁnal conclu-
sion differed, they were resolved by discussion, leading to a
consensus. Three subgroup analyses were performed: aortic
grafts (deﬁned as grafts with at least one aortic anasto-
mosis), extra anatomic/subcutaneous grafts, and early
(within 1 year after implantation) versus late PET scans.
Data were collected and processed using the Statistical
Package for the Social Sciences version 20.0 (SPSS, IBM,
Armonk, NY, USA).
Data were analyzed anonymously and retrospectively.
Retrospective patient data research does not fall under the
scope of Dutch law on human research, therefore ethical
approval was not required.
RESULTS
Seventy-three patients with a central vascular graft im-
plantation underwent PET scanning for various reasons.
After excluding incomplete scans and scans made prior to
graft implantation, 53 patients with 59 grafts (53 PET scans)
were included in the present study. None of the included
patients had had previous operations for vascular graft in-
fections at other institutions. There were 27 uninfected
grafts and 32 infected grafts. Patients with uninfected grafts
had a median age of 69.3 years (IQR 57.3e70.7) and con-
sisted of 22 (82%) males. Patients with infected grafts had a
median age of 66.0 years (IQR 55.5e68.2) and consisted of
22 (69%) males. The indications for PET scans for the un-
infected grafts were malignancy (n ¼ 18, 67%), suspected
vascular graft infection (n ¼ 7, 26%), and unknown infection
(n ¼ 2, 7%). In the latter two groups (n ¼ 9) an infection
was ruled out. All PET scans in the infected group were
performed for a suspected vascular graft infection. Median
time between graft implantation and PET scan was 4.3 years
Table 2. Surgical procedures.
Uninfected
grafts, n (%)
Infected
grafts, n (%)
Operation indication
Aortic aneurysm 17 (63) 20 (63)
Stenosing aortic disease 10 (37) 7 (22)
Other 0 5 (16)
Operation type
Aorta
Tube 4 (15) 4 (13)
Aorto-bi-iliac 4 (15) 5 (16)
Aorto-bi-femoral 6 (22) 5 (16)
Aorto-uni-iliac-uni-femoral 0 1 (3)
Differential FDG-PET Uptake Patterns 379(IQR 2.7e7.9) for the uninfected grafts and 3.9 years (IQR
0.6e6.9) for the infected grafts. Patient characteristics are
shown in Table 1. The sedimentation rate was statistically
signiﬁcantly higher in the infected graft group as well as
clinical parameters (p < .05). In both the uninfected and
infected groups, the predominant indication for central
vascular reconstruction was an abdominal aortic aneurysm
(63%). Details on the surgical procedures are shown in
Table 2. Most patients underwent separate computed to-
mography (CT) scanning around the time of PET scanning.
Table 3 shows the different CT parameters and the corre-
lation with the PET results.Ilio-femoral 1 (4) 3 (9)
Extra-anatomic bypass
Axillo-bi-femoral 1 (4) 3 (9)
Axillo-uni-femoral 1 (4) 0
Axillo-popliteal 0 3 (9)
Femoro-femoral crossover 5 (19) 1 (3)
EVAR
Bifurcation 3 (11) 5 (16)
Aorto-uni-iliac with femoro-
femoral crossover
2 (7) 1 (3)
TEVAR 0 1 (3)Maximum standardized uptake value (SUVmax)
Median SUVmax was 3.3 (IQR 2.0e4.2) for the uninfected
grafts and 5.7 for the infected grafts (IQR 2.2e7.8). AUC
was 0.80 (95% CI 0.67e0.93). Using a cutoff value of 5.5
yielded a sensitivity of 80% (95% CI 60e100%), and speci-
ﬁcity of 81% (95% CI 69e93%). Fig. 2 shows that the SUV-
max distributions for the uninfected and infected grafts
largely overlap.Table 1. Basic patient characteristics.
Uninfected
grafts (No, %)
Infected
grafts (No, %)
Total number of grafts, n 27 32
Age, years (mean  SD) 69.3  9.3 66.0  8.1
Male sex 22 (82) 22 (69)
Comorbidities
Smoking 12 (48) 18 (60)
Diabetes 3 (11) 4 (13)
Hypertension 9 (33) 16 (50)
Cardiac (SVS class 1,2 or 3) 9 (33) 14 (44)
Pulmonary (SVS class 1,2
or 3)
9 (33) 5 (16)
Laboratory parameters
Leucocytes, *109/L, mean
(range, SD)
9.3
(4e15.6, 3.3)
9.1
(2.9e18.6, 3.3)
C-reactive protein, mg/L,
mean (range, SD)
55.8
(8e144, 55.0)
47.4
(5e162, 40.1)
Sedimentation, mm after 1
hour, mean (range, SD)
16.8
(7e42, 16.9)
64.7
(8e140, 38.2)
Clinical and CT parameters
Positive blood cultures 0 9 (28)
Fever 0 24 (75)
Incisional ﬁstula 0 8 (25)
Exposed graft 0 5 (16)
Fluid surrounding graft 0 11 (34)
Air surrounding graft 0 7 (22)
>20 HU peri-graft soft tissue 3 (11) 19 (59)
Time between graft
implantation and PET scan,
years, mean (range)
4.3 (0.0e14.2) 3.9 (0.0e20.2)
Indication for PET scan
Malignancy 18 (67) 0
Suspected graft infection 7 (26) 32 (100)
Unknown infection 2 (7) 0
CT ¼ computed tomography; HU ¼ Hounsﬁeld units; SVS ¼
Society for Vascular Surgery.
EVAR ¼ endovascular aneurysm repair; TEVAR ¼ thoracic
endovascular aneurysm repair.Tissue to background ratio (TBR)
Median TBR was 2.0 (IQR 1.4e2.5) for the uninfected grafts
and 3.2 for the infected grafts (IQR 1.5e3.5). The AUC was
0.76 (95% CI 0.62e0.89). Using a cutoff value of 3 yielded a
sensitivity of 73% (95% CI 51 96%), speciﬁcity of 71% (95%
CI 58e85%). Fig. 3 shows the TBR distributions for unin-
fected and infected grafts to be largely overlapping.Visual grading scale (VGS)
Fig. 4 shows the results of the VGS. VGS was subdivided into
low probability for AGI (VGS 0, 1, and 2) and high proba-
bility (VGS 3 and 4). This yielded a sensitivity of 72% (95% CI
56e89%) and speciﬁcity of 56% (95% CI 37e74%).Focality
A focal FDG uptake was observed in 26% of the uninfected
compared with 69% of the infected grafts (Fig. 5). FocalityTable 3. CT ﬁndings and correlation with PET studies.
Uninfected
grafts
Infected
grafts
Negative
PET result
Positive
PET result
Peri-graft air 0 7 0 7
No peri-graft air 4 15 7 12
Peri-graft ﬂuid 0 11 0 11
No peri-graft ﬂuid 3 12 7 8
>20 HU peri-graft
soft tissue
3 19 7 15
<20 HU peri-graft
soft tissue
1 3 1 3
HU ¼ Hounsﬁeld units.
Figure 2. SUVmax distribution in uninfected and infected grafts.
Figure 3. TBR distribution in uninfected and infected grafts.
Figure 5. Homogenous and focal FDG uptake in uninfected and
infected grafts.
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(95% CI 48e83%) and speciﬁcity of 74% (95% CI 58e91%).
Final conclusion based only on imaging
The ﬁnal conclusion of the PET scans was made using all
available PET information (SUVmax, TBR, VGS, and focality).Figure 4. Visual grading scale distribution in uninfected and
infected grafts.Most of the uninfected grafts were judged clearly not
infected or probably not infected (24 out of 27, 89%). Most
of the infected grafts were judged clearly infected or
probably infected (21 out of 32, 66%) (Fig. 6). Subdividing
the conclusion into uninfected (clearly uninfected or prob-
ably uninfected) and infected (doubtful, probably infected,
or clearly infected) yielded a sensitivity of 77% (95% CI 62e
92%) and a speciﬁcity of 89% (95% CI 77e100%).Aortic grafts
The distributions of SUVmax, TBR, VGS, focality, and the
ﬁnal conclusion also largely overlapped in uninfected
(n ¼ 14) and infected grafts (n ¼ 15), when the analysis was
restricted to aortic grafts (supplemental Figures S1eS5).Subcutaneous grafts
The distributions of SUVmax, TBR, VGS, focality, and the
ﬁnal conclusion also largely overlapped in uninfected
(n ¼ 7) and infected grafts (n ¼ 7), when the analysis was
restricted to extra anatomic, subcutaneous grafts
(supplemental Figures S6eS10).
Early versus late PET scans. An early PET scan within 12
months of graft implantation was performed in six unin-
fected grafts and 12 infected grafts. A late PET scan was
performed in 21 uninfected and 20 infected grafts. The
qualitative parameters in this subgroup analysis showed the
same overlap as for the total group. In the early group, the
VGS detected all six uninfected grafts (100%). Of the early
infected grafts, 82% showed focal uptake. Of the uninfected
grafts in the early groups, 100% could be identiﬁed by the
ﬁnal conclusion. In the late group, the same overlap be-
tween uninfected and infected grafts was seen for SUVmax,Figure 6. Final conclusion of the PET scans.
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group.DISCUSSION
This study reports the distribution of SUVmax, TBR, VGS,
focality of FDG uptake, and ﬁnal conclusion in uninfected
and infected central vascular grafts (CVG). It is the ﬁrst to
show that FDG uptake patterns in uninfected CVGs largely
overlap with those of infected CVGs.
Only limited studies have shown that uninfected grafts
are indeed able to display FDG uptake. One study reported
on 16 patients with aortic grafts in which FDG uptake was
demonstrated in 11, while only one of these grafts was
deemed infected.14 In another study, 102 PET scans in 42
patients with 107 uninfected vascular grafts were
analyzed.10 FDG uptake was noted in 98 grafts (92%). The
amount of FDG uptake can be expressed by SUVmax and
TBR. The role of SUVmax and TBR in diagnosing increased
FDG uptake has not been established for uninfected or
infected grafts. Considering the large overlap of SUVmax
and TBR in uninfected and infected grafts in the present
study, cutoff values will be difﬁcult to establish.
Of the quantitative parameters used to interpret PET im-
ages, only focal uptake has been shown to accurately predict
infection.8,18 In a series by Keidar et al., a diffuse homoge-
nous uptake was noted in 67 uninfected grafts (63%) and in-
homogenous uptake was noted in 31 grafts (29%). No grafts
displayed focal FDG uptake.10 In the present study, however,
focal and homogenous FDG uptake were observed in both
uninfected and infected central vascular grafts. Spacek et al.
reported that focal uptake was associated with a vascular
graft infection with a sensitivity of 78% (95% CI 67e89%) and
speciﬁcity of 93% (95%CI 85e100%). These estimates could
not be reproduced in the present study (sensitivity of 66%,
95% CI 48e83%, and speciﬁcity of 74%, 95% CI 58e91%).
One important difference between the study by Spacek et al.
and the present study is the deﬁnition of proven graft
infection. While in the present study, a graft infection was
considered proven on microbiological or clinical parameters,
Spacek et al. used positive microbiological or histopatho-
logical ﬁndings. This may have led to an underestimation of
infections in the latter study.
No quantitative parameter of the FDG-PET scan could be
identiﬁed that could reliably differentiate between unin-
fected and infected grafts. This limits the usefulness of
these individual parameters in identifying infected grafts. Of
the qualitative parameters, only the ﬁnal conclusion
seemed to be able to provide some differentiation. There is
no clear explanation for this ﬁnding. Apparently, the indi-
vidual parameters add up to a subjective threshold above
which a graft is deemed either uninfected or infected.
Multivariate analysis with a larger patient population with
different weighting schemes of the individual parameters is
required to explain this issue.
In the present study, two different groups were created.
It may be debated whether three different groups (non-
infected, proven infected, or suspicious graft infections)would better reﬂect clinical reality. The non-infected group
would have been straightforward, containing only patients
with a malignancy. The proven infected group, however,
would pose some problems. Cultures are the gold standard
to prove infection but the use of antibiotics and bioﬁlm
forming microorganisms limits the value of cultures in graft
infections. By including only culture proven infections in the
proven infection group, some high grade infections, the
clinical infections, and some low grade infections would be
missed. This would underestimate the true incidence of
graft infection and inﬂate the suspicious graft infection
group. Together with the risk of ending up with small
numbers, it was decided to cluster the patients with proven
infection and compare those with proven uninfected grafts.
In the present study a standard interval between FDG
administration and the start of PET acquisition (60 minutes)
was used. Although some authors mention the possible
added value of late FDG-PET imaging for infection detec-
tion, this is mostly based on case studies and most evidence
for late FDG-PET imaging is aimed at malignancy. The cur-
rent guidelines for FDG-PET imaging therefore do not
advocate late imaging for infection detection.
It can be postulated that concomitant pathologies, like
malignancies or cardiovascular diseases inﬂuence graft FDG
uptake. However, as uptake in large tumors for instance,
does not affect normal FDG uptake in the liver, muscles, and
brain, it is unlikely that concomitant uptake will inﬂuence
the uptake in the vascular grafts.
The strengths of this study are that it is the ﬁrst study to
describe the FDG uptake patterns in uninfected and infected
central vascular grafts, it compares SUVmax, TBR, VGS, and
focality of FDG uptake in uninfected and infected central
vascular grafts, and all PET-FDG parameters were indepen-
dently assessed by two observers, blinded for clinical data.
The following limitations of this study need to be
addressed. First, normal FDG uptake patterns may differ
according to graft location. In the present study stent grafts,
subcutaneous grafts, as well as aortic grafts were included.
The numbers in the present study were too small to
determine differences in uptake patterns, stratiﬁed for graft
location. With the low incidence of aortic graft infections
(AGI), a (inter)national registry would probably be the only
way to analyze uptake patterns in the different graft groups.
However, the present subgroup analysis of aortic and sub-
cutaneous grafts showed the same overlap between FDG
uptake patterns of uninfected and infected grafts as for the
total group. The small numbers in the present study illus-
trates the difﬁculties of research on graft infections. A graft
infection registry may prove valuable for further research
on FDG uptake patterns in uninfected vascular grafts. Sec-
ond, different graft materials provoke different inﬂamma-
tory reactions and may therefore yield a different normal
FDG uptake pattern. All the aortic and subcutaneous grafts
in the present study, however, were made of polyester. The
effect of graft material on normal uptake patterns will
probably be mild in the present study. Third, in the present
study patients with different anatomical conﬁgurations,
clinical situations, and operative details were analyzed as a
Code Surgical procedure
333152Y Aorta, operative treatment traumatic aorta
rupture, thoracic, endovascular bifurcation graft
333153A Aorta, operative treatment thoracic aneurysm,
non-ruptured, tube graft
333153B Aorta, operative treatment thoracic aneurysm,
ruptured, tube graft
333153C Aorta, operative treatment abdominal-thoracic
aneurysm, non-ruptured, tube graft
333153D Aorta, operative treatment abdominal-thoracic
aneurysm, non-ruptured, bifurcation graft
333153E Aorta, operative treatment abdominal-thoracic
aneurysm, ruptured, tube graft
333153F Aorta, operative treatment abdominal-thoracic
aneurysm, ruptured, bifurcation graft
333153H Aorta, thoracic aneurysm, percutaneous
prosthesis
333530E Aorta, operative treatment abdominal aneurysm,
non-ruptured, tube graft
333530F Aorta, operative treatment abdominal aneurysm,
non-ruptured, bifurcation graft
333530H Aorta, operative treatment abdominal aneurysm,
non-ruptured, endovascular bifurcation graft
333530K Aorta, operative treatment abdominal aneurysm,
ruptured, bifurcation graft
333530J Aorta, operative treatment abdominal aneurysm,
ruptured, tube graft
333530N Aorta, operative treatment abdominal aneurysm,
endovascular tube graft
333530P Aorta, operative treatment abdominal aneurysm,
ruptured, endovascular bifurcation graft
333545A Iliac artery, operative treatment iliac aneurysm,
non-ruptured
333545B Iliac artery, operative treatment iliac aneurysm,
ruptured
333551A Mesenteric artery, reconstruction, synthetic
interposition graft
333552 Aortoiliac bypass graft
333552B Mesenteric artery, reconstruction, synthetic
bypass graft
333552C Aorta, aorto-femoral bypass
333553 Aorta, tube graft
333558 Aorta, aorto-iliac-aorto-ilio-femoral bifurcation
graft
333594 Aorta, excision infected prosthetic aorto/iliac
graft
333672 Axillo-popliteal bypass
333673 Femoro-femoral bypass
333674C Obturator bypass
333679 Iliac artery, Iliaco-femoral bypass
382 P. Berger et al.group, as a concession to statistical limitations. Despite
lumping together these clinically very different procedures,
the present analyses display some important messages,
which should be further addressed in future and more
speciﬁc studies. Fourth, there was a large range between
implantation and PET scanning. This means that patients
were analyzed during different stages of infection or
inﬂammation. In an ideal study set up, multiple scans would
be performed at ﬁxed times (e.g. 1, month, 3 month, 1
year). However, this study used retrospective registry data,
which reﬂect daily clinical practice but also imply that the
time between operation and PET scan can vary considerably
between patients.
Finally, only the ﬁrst PET scan performed after central
aortic graft implantation was assessed. The temporal
changes of FDG uptake patterns in the immediate post-
operative period have not been studied. The healing of
the surgical trauma associated with a vascular graft im-
plantation is characterized by several inﬂammatory stages.
After the ﬁrst hemostatic phase, the inﬂammatory phase
occurs, which lasts for up to a couple of weeks. As FDG
accumulates in inﬂammatory cells, these phases are asso-
ciated with an increased FDG uptake. This uptake is gener-
ally said to be mild to moderate. After this phase the
proliferation phase begins, in which new granulation tissue
is created and angiogenesis takes place. Theoretically this
phase can also show an increased FDG uptake. Although
this uptake is probably less than that of the inﬂammatory
phase, a PET scan during this phase can potentially induce
false positive results. After these three phases, remodeling
occurs. This is only a very mild inﬂammatory phase which
can last for a prolonged period of time. The peak of in-
ﬂammatory FDG uptake in the post-operative phase
therefore occurs during the ﬁrst couple of weeks, during
which the value of a PET scan in the diagnosis of vascular
graft infections is diminished. Larger studies are needed to
assess the effect of post-operative timing of the PET scan on
the normal FDG uptake patterns. Larger studies are needed
to assess the effect of post-operative timing of the PET scan
on the normal FDG uptake patterns.
CONCLUSIONS
Patterns of FDG uptake in uninfected grafts largely overlap
with those of infected vascular grafts. This limits the diag-
nostic value of the individual parameters of the PET scan
(SUVmax, TBR, VGS, and focality of FDG uptake) in identi-
fying or ruling out infected grafts. To further specify the
potential of FDG PET scanning, more data are needed on
the normal uptake patterns associated with vascular graft
implantation. A larger study is needed, in which potential
confounding factors are ruled out. Ideally this should be a
study in which only patients with a speciﬁc graft location
and graft material are included and compared during a
predetermined post-operative period.
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